Zhongzhi Pharmaceutical Holdings (HKSE:03737) EPS (Basic): HK$0.02 (TTM As of Dec. 2025)


HKSE:03737 Zhongzhi Pharmaceutical Holdings Ltd HKSE:03737
53 GF Score
Price HK$0.71
GF Value HK$0.89
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Zhongzhi Pharmaceutical Holdings EPS (Basic)?

Zhongzhi Pharmaceutical Holdings HKSE:03737 53 EPS (Basic) is HK$0.02 as of Dec. 2025. GuruFocus rates HKSE:03737 with a GF Score™ of 53/100 and a GF Value™ of HK$0.89 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Zhongzhi Pharmaceutical Holdings's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was HK$0.01. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.02.

Zhongzhi Pharmaceutical Holdings's EPS (Diluted) for the six months ended in Dec. 2025 was HK$0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.02.

Zhongzhi Pharmaceutical Holdings's EPS without NRI for the six months ended in Dec. 2025 was HK$0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.03.

During the past 12 months, Zhongzhi Pharmaceutical Holdings's average EPS without NRIGrowth Rate was -80.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -43.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -23.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was -3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 12 years, Zhongzhi Pharmaceutical Holdings's highest 3-Year average EPS without NRI Growth Rate was 25.20% per year. The lowest was -43.90% per year. And the median was 1.70% per year.

Zhongzhi Pharmaceutical Holdings  (HKSE:03737) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Zhongzhi Pharmaceutical Holdings EPS (Basic) Related Terms

Zhongzhi Pharmaceutical Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Zhongzhi Pharmaceutical Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongzhi Pharmaceutical Holdings EPS (Basic) Chart

Zhongzhi Pharmaceutical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.15 0.21 0.12 0.02

Zhongzhi Pharmaceutical Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.11 0.01 0.01 0.01
HKSE:03737
53GF Score
Zhongzhi Pharmaceutical Holdings Ltd HKSE:03737
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongzhi Pharmaceutical Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Zhongzhi Pharmaceutical Holdings's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(19.101-0)/823.448
=0.02

Zhongzhi Pharmaceutical Holdings's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(9.398-0)/803.151
=0.01

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of HK$0.02 mean?
Zhongzhi Pharmaceutical Holdings (HKSE:03737) has a EPS (Basic) of HK$0.02 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Zhongzhi Pharmaceutical Holdings and its competitors.
Is Zhongzhi Pharmaceutical Holdings' EPS (Basic) too high?
Zhongzhi Pharmaceutical Holdings' current EPS (Basic) is HK$0.02. Overall, Zhongzhi Pharmaceutical Holdings has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhi Pharmaceutical Holdings' EPS (Basic) compare to ZTS?
Zhongzhi Pharmaceutical Holdings' EPS (Basic) of HK$0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Zhongzhi Pharmaceutical Holdings and its competitors. Zhongzhi Pharmaceutical Holdings's current EPS (Basic) is HK$0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhi Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhi Pharmaceutical Holdings (HKSE:03737) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.89, compared to a current price of HK$0.71 — trading 20.2% below its estimated fair value. The current EPS (Basic) is HK$0.02. Zhongzhi Pharmaceutical Holdings' overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Zhongzhi Pharmaceutical Holdings (HKSE:03737), the current EPS (Basic) is HK$0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongzhi Pharmaceutical Holdings (HKSE:03737) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongzhi Pharmaceutical Holdings stock appears to be undervalued. The current stock price of HK$0.71 is trading 20.2% below its estimated GF Value™ of HK$0.89. GuruFocus considers Zhongzhi Pharmaceutical Holdings to be Modestly Undervalued.

Key valuation signals for HKSE:03737:

  • EPS (Basic): HK$0.02
  • GF Value™: HK$0.89 vs. price of HK$0.71 (20.2% below fair value)
  • GF Score™: 53/100 with 8 warning signs

No single metric tells the full story. See the HKSE:03737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhongzhi Pharmaceutical Holdings Business Description

Address No. 3 Kangtai Road South, Torch Development Zone, Guangdong Province, Zhongshan, CHN
Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products in the PRC. The Group is a large industrial and trading enterprise group featuring researching, producing, and selling traditional Chinese medicine preparations, prepared slices of Chinese crude drugs, and foods. Its products include Shenqi Koufuye, Yinhuang Jiaonang, Yinhuang Keli, and others. Its segments are the pharmaceutical manufacturing segment, which generates maximum revenue, is engaged in the research and development, manufacturing, and sale of Chinese patent medicines and decoction pieces consisting of traditional decoction pieces and modern decoction pieces, and the operation of the chain pharmacies segment.
53GF Score

Get the complete analysis for HKSE:03737

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.71
Price
HK$0.89
GF Value